Kura Oncology, Inc. (KURA) earnings
Quarterly results of Kura Oncology, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Kura Oncology, Inc. was expected to report around November 3, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Kura Oncology, Inc. reported revenue of $20.9M (+36.5% on the same quarter a year earlier) and a net loss of $68.3M.
Diluted earnings per share were -$0.77.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | $20.9M | +36.5% | -$68.3M | -$0.77 |
| Q1 FY2026 | $18.3M | +29.5% | -$73.3M | -$0.83 |
| Q4 FY2025 | $17.3M | - | -$81M | - |
| Q3 FY2025 | $20.8M | - | -$74.1M | -$0.85 |
| Q2 FY2025 | $15.3M | - | -$66.1M | -$0.75 |
| Q1 FY2025 | $14.1M | - | -$57.4M | -$0.66 |
| Q4 FY2024 | - | - | -$19.2M | - |
| Q3 FY2024 | - | - | -$54.4M | -$0.63 |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Annual report 10-K
- Quarterly results 8-K
When is Kura Oncology, Inc.'s next earnings date?
Kura Oncology, Inc. was expected to report around November 3, 2026; nothing is on file with the SEC yet.
What were Kura Oncology, Inc.'s latest quarterly results?
For Q2 FY2026, which ended June 30, 2026, Kura Oncology, Inc. reported revenue of $20.9M and a net loss of $68.3M. The figures come from its filing with the SEC.
Is Kura Oncology, Inc.'s revenue growing?
Revenue in Q2 FY2026 was $20.9M, up 36.5% from $15.3M in the same quarter a year earlier.
Get an email when KURA reports
Follow KURA and we email you its next results the day they are filed, with the numbers explained.